Scientists at Yale University have identified a set of plasma biomarkers that could reasonably predict the risk of metastasis among patients with melanoma, according to findings published in Clinical Cancer Research, a journal of the American Association for Cancer Research. “The rate at which melanoma is increasing is dramatic, and there is a huge number of patients under surveillance,” said Harriet Kluger, M.D., associate professor of medicine at Yale University School of Medicine. “O...